XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain - StreetInsider.com

Submitted by Anonymous (not verified) on Wed, 09/08/2021 - 22:38

XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain  StreetInsider.com